|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 548.05 INR | +2.20% |
|
+2.66% | +2.34% |
| Capitalization | 1,355B 14.96B 12.74B 11.9B 11.2B 20.62B 22.52B 139B 53.89B 639B 56.12B 54.94B 2,330B | P/E ratio 2026 * |
32.2x | P/E ratio 2027 * | 27.5x |
|---|---|---|---|---|---|
| Enterprise value | 1,326B 14.64B 12.47B 11.65B 10.96B 20.18B 22.05B 136B 52.74B 625B 54.93B 53.77B 2,280B | EV / Sales 2026 * |
3.12x | EV / Sales 2027 * | 2.71x |
| Free-Float |
30.8% | Yield 2026 * |
0.39% | Yield 2027 * | 0.44% |
Last Transcript: Ambuja Cements
| 1 day | +2.20% | ||
| 1 week | +2.66% | ||
| Current month | -0.35% | ||
| 1 month | -2.55% | ||
| 3 months | -2.21% | ||
| 6 months | -0.05% | ||
| Current year | +2.34% |
| 1 week | 523.3 |  | 549.9 |
| 1 month | 523.3 | | 565.35 |
| Current year | 455 | | 625 |
| 1 year | 455 | | 625 |
| 3 years | 315.3 | | 706.85 |
| 5 years | 225.9 | | 706.85 |
| 10 years | 136.65 | | 706.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-03-31 | |
Rohit Soni
DFI | Director of Finance/CFO | - | 2025-11-21 |
Manish Mistry
CMP | Compliance Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2025-03-31 | |
| Chairman | 63 | 2022-09-15 | |
| Director/Board Member | 38 | 2022-09-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.20% | +2.66% | -4.19% | -6.29% | 14.96B | |
| -0.46% | +5.78% | +28.26% | +229.77% | 84.72B | |
| -0.75% | +2.28% | +78.74% | +336.60% | 46.07B | |
| -1.11% | +0.36% | +6.41% | +60.71% | 39.1B | |
| -0.61% | +0.62% | +12.83% | +74.59% | 37.89B | |
| +2.19% | +1.09% | -1.13% | +64.03% | 38.07B | |
| -0.09% | +1.12% | - | - | 30.82B | |
| +1.39% | +3.27% | +6.64% | +56.27% | 21.25B | |
| +1.93% | +2.29% | +80.85% | +141.42% | 16.14B | |
| -0.46% | -3.00% | +27.58% | +6.51% | 8.64B | |
| Average | +0.42% | +1.00% | +26.22% | +107.07% | 33.77B | |
| Weighted average by Cap. | +0.09% | +0.94% | +27.17% | +150.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 425B 4.69B 3.99B 3.73B 3.51B 6.46B 7.06B 43.55B 16.89B 200B 17.59B 17.22B 730B | 485B 5.35B 4.56B 4.26B 4.01B 7.38B 8.06B 49.74B 19.29B 229B 20.09B 19.67B 834B |
| Net income | 45.09B 498M 424M 396M 373M 686M 750M 4.62B 1.79B 21.25B 1.87B 1.83B 77.54B | 49.51B 547M 466M 435M 409M 753M 823M 5.08B 1.97B 23.34B 2.05B 2.01B 85.14B |
| Net Debt | -28.74B -317M -270M -253M -238M -437M -478M -2.95B -1.14B -13.55B -1.19B -1.17B -49.43B | -38.25B -422M -360M -336M -316M -582M -636M -3.92B -1.52B -18.03B -1.58B -1.55B -65.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 548.05 ₹ | +2.20% | 99,594 |
| 25-12-11 | 536.25 ₹ | +1.25% | 22,089 |
| 25-12-10 | 529.65 ₹ | -0.63% | 18,160 |
| 25-12-09 | 533.00 ₹ | +0.71% | 114,177 |
| 25-12-08 | 529.25 ₹ | -0.86% | 61,583 |
Delayed Quote Bombay S.E., December 12, 2025 at 05:20 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMBUJACEM Stock
Select your edition
All financial news and data tailored to specific country editions
